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Expression of the Blue-Light Receptor Cryptochrome in
the Human Retina
Carol L. Thompson,1 Catherine Bowes Rickman,2,3 Steven J. Shaw,2 Jessica N. Ebright,2
Una Kelly,2 Aziz Sancar,1 and Dennis W. Rickman2,4
PURPOSE. To analyze the patterns of expression of the crypto-
chromes, CRY1 and CRY2, in the human retina and to correlate
expression of these putative blue-light receptors with nonvi-
sual photoreceptor localization.
METHODS. CRY1 and CRY2 mRNA expression was analyzed in
4-mm diameter punches of macula and midperipheral human
retina by quantitative RT-PCR. CRY2 protein expression was
examined by immunohistochemistry in cross sections of hu-
man retina, and its subcellular localization was determined by
immunoblot analysis of fractionated human retinal extracts.
RESULTS. CRY2 mRNA was 11 times more abundant than CRY1
throughout adult human retina. CRY2 immunoreactivity was
detected in most cells in the ganglion cell layer (GCL) and in a
subset of cells in the inner nuclear layer (INL) in both the
macula and periphery. Immunoperoxidase staining further re-
vealed that CRY2 was localized throughout the cytoplasm of
cells in the GCL as well as within nuclei. This intracellular
localization of CRY2 was confirmed by immunoblot analysis of
fractionated human retinal extracts.
CONCLUSIONS. Photopigments governing circadian photorecep-
tion have been localized to the inner retina. The relative abun-
dance of CRY2 transcripts, coupled with CRY2 localization to
the inner retina, supports a photoreceptive role for CRY2 in
human retina. Furthermore, the discovery that CRY2 is also
localized within the cytoplasm of some cells in the GCL, sug-
gests it may perform a function separate from its known nu-
clear role in the transcriptional feedback loop underlying the
molecular circadian clock. (Invest Ophthalmol Vis Sci. 2003;
44:4515–4521) DOI:10.1167/iovs.03-0303
The retina is the only tissue in mammals that regulatesphotoreception, both visual and nonvisual.1 Nonvisual
photoreception encompasses multiple responses to light such
as circadian photoentrainment and pupillary light responses,
and unlike vision, which is known to be regulated by the rod
and cone photoreceptors of the outer retina, these nonvisual
irradiance detection tasks occur through poorly understood
photoreceptive pathways. In the rd mouse with retinal degen-
eration caused by a mutation in the -subunit of cGMP phos-
phodiesterase,2 complete rod photoreceptor cell loss occurs
by 3 weeks of age followed by degeneration of cone photore-
ceptors by 3 months.3 However, these mice retain robust
circadian responses to light,4,5 indicative of the existence of a
novel photopigment in the inner retina. Candidate photorecep-
tive molecules include a novel opsin, melanopsin, and a sepa-
rate class of blue-light photoreceptors, cryptochromes.
Melanopsin is a recently discovered opsin expressed in the
inner retina of the mouse and human. In the mouse retina,
melanopsin is restricted to a small subset of cells in the gan-
glion cell layer (GCL)6 that are directly photoresponsive.7,8
However, mice without melanopsin still have robust circadian
photoresponses9,10 and pupillary light responses.11 Therefore,
because the requirement for melanopsin-expressing, photosen-
sitive ganglion cells to circadian photoreception in particular
and nonvisual photoreception in general remains speculative,
the existence of an additional photoreceptive molecule is
highly probable.
Cryptochromes, in contrast, represent an entirely different
class of photopigments, belonging to the photolyase blue-light
receptor family. Unlike the retinaldehyde-based opsins, cryp-
tochromes use two light-absorbing cofactors: flavin adenine
dinucleotide and methenyltetrahydrofolate.12 In human and in
mouse, there are two cryptochromes: CRY1 and CRY2.13 In
cry1/ and cry2/ single knockout mice, circadian photo-
responses are abnormal, indicating that these proteins may
indeed be circadian photopigments.14,15 However, these pro-
teins are also intimately involved in intrinsic circadian clock
function, introducing an element of complexity when inter-
preting the dramatic reduction in photoresponsiveness we
have observed in the double-mutant cry1/cry2/
mice.15,16 In situ localization of cryptochrome mRNAs in the
mouse suggests that the two cryptochromes are not com-
pletely redundant.17 These studies support a predominantly
circadian clock regulatory function for cry1, which is highly
expressed in the mouse suprachiasmatic nucleus (SCN), and a
predominantly photoreceptive function for cry2, which is
highly expressed in the mouse retina.17
Evidence for cryptochromes as circadian photopigments
also exists in other species, including Drosophila and ze-
brafish. In Drosophila, for example, the cryptochrome muta-
tion cryb, which affects flavin binding in the sole fruit fly
cryptochrome, results in loss of certain light-regulated types of
behavior, including phase-shifting by light.18,19 In zebrafish,
where heart and kidney (and even a cell line isolated from the
zebrafish embryo) are as responsive to light as retina,20 the
nonvisual photoresponsive cells express at least four crypto-
chromes and display an action spectrum consistent with peak
absorption of cryptochrome.21 In addition, cryptochrome
plays an important role in mammalian pupillary constriction.
Recent data indicate that the pupillary responses of mice with-
out rods, cones, and cryptochromes are only 5% as sensitive to
blue light as those of mice lacking only rods and cones.22
From the 1Department of Biochemistry and Biophysics, University
of North Carolina School of Medicine, Chapel Hill, North Carolina; and
the Departments of 2Ophthalmology, 3Cell Biology, and 4Neurobiol-
ogy, Duke University Medical Center, Durham, North Carolina.
Supported by National Eye Institute R01-EY11286 (CBR), R01-
EY11389 (DWR), and P30-EY05722 (Duke University Eye Center);
Grant R01-GM31082 from the National Institute of General Medical
Sciences (AS); and a Career Development Award from Research to
Prevent Blindness (CBR).
Submitted for publication March 25, 2003; revised May 31, 2003;
accepted June 5, 2003.
Disclosure: C.L. Thompson, None; C.B. Rickman, None; S.J.
Shaw, None; J.N. Ebright, None; U. Kelly, None; A. Sancar, None;
D.W. Rickman, None
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be marked “advertise-
ment” in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Corresponding author: Dennis W. Rickman, Department of Oph-
thalmology, Duke University Medical Center, Erwin Road, Box 3802,
Durham, NC 27710; dennis.rickman@duke.edu.
Investigative Ophthalmology & Visual Science, October 2003, Vol. 44, No. 10
Copyright © Association for Research in Vision and Ophthalmology 4515
Downloaded from iovs.arvojournals.org on 09/14/2021
The accumulating genetic evidence supporting a photore-
ceptive function for cryptochromes in the mouse and other
species suggests cryptochromes could function as photorecep-
tors in humans. There has been no analysis of cryptochrome
expression or localization in human retina to date, and even in
the mouse, cryptochrome expression in the retina has not yet
been examined in detail. Therefore we examined mRNA ex-
pression profiles of CRY1 and CRY2, as well as CRY2 protein
expression in the human retina, to gain further insight into the
functions of these proteins.
MATERIALS AND METHODS
Real-Time Quantitative RT-PCR
Human donor eyes were obtained within 4 hours of death from the
North Carolina Eye Bank (Table 1). Total retinal RNA was isolated from
4-mm trephine punches of two separate regions of neural retina,
macula, and midperipheral retina, DNase treated, and quantitated us-
ing an RNA quantitation reagent (RiboGreen; Molecular Probes, Eu-
gene, OR), as described previously.23 Total human placental RNA was
purchased from BD Biosciences-Clontech (Palo Alto, CA). First-strand
cDNAs were synthesized from equal amounts of total RNA (1 g/
reaction) with a cDNA synthesis kit (iScript) as described by the
manufacturer (Bio-Rad, Hercules, CA).
Real-time quantitation of CRY1 and CRY2 mRNAs normalized to an
endogenous reference, -actin (ACTB), was performed using the
iCycler iQ detection system (Bio-Rad) as previously described.23
Briefly, a PCR master mix (iQ Supermix, Bio-Rad) for each gene-specific
primer (GSP) pair (Table 2) with each cDNA template was prepared.
Reactions consisted of 1 L of template cDNA/20-L reaction, 2 PCR
master mix, 10 nM fluorescein calibration dye (Bio-Rad), 1 L of a
1:1500 dilution of 10,000 nucleic acid dye (SYBR Green 1; Molecular
Probes) and 500 nM of each GSP pair. Duplicate reactions were
amplified using the following PCR amplification protocol: 95°C for 2
minutes followed by 50 cycles of 95°C for 15 seconds, 60°C for 15
seconds, and 72°C for 15 seconds. The increase in fluorescence was
measured in real time during the extension step, and melt curves were
obtained immediately after amplification by increasing temperature in
0.4°C increments from 65°C for 85 cycles of 10 seconds each and
analyzed using the analysis software that accompanied the system
(iCycler; Bio-Rad). Amplification of a single PCR product per primer
pair was verified by the presence of a single melting temperature peak
on each melt curve and by analysis on a 4.5% acryl agarose gel (DNA
Technologies Inc., Gaithersburg, MD). The threshold cycle (CT) was
the cycle at which the amount of amplified sample reached a fixed
threshold of 100 relative fluorescence units (RFU). The fold difference
between CRY1 or CRY2 normalized to the endogenous control gene
(ACTB) and relative to CRY1 in peripheral retina was calculated by the
comparative CT method (2
CT) as described by the manufacturer
(Prism 7700 Sequence Detection System; Applied Biosystems, Inc.,
Foster City, CA). We demonstrated equal PCR amplification efficiencies
of each target cDNA sequence in the peripheral retina cDNA sample on
a PCR standard curve with a correlation coefficient of 0.999 and a PCR
amplification efficiency of 94.6% (data not shown).
Immunohistochemistry
Human donor eyes were preserved within 4 hours of death by immer-
sion in 4% paraformaldehyde for 6 hours after removal of the cornea
and lens (Table 1). Eyes were stored at 4°C in 1% paraformaldehyde
until use. Five-millimeter trephine punches of the macula and midpe-
ripheral retina were obtained, cryoprotected, and cryosectioned. Cryo-
sections (10 m) were washed in several changes of PBS. All steps
were performed at room temperature unless otherwise indicated.
Tissue sections were incubated in 0.02 mg/mL affinity-purified CRY2
antibody (ADI, San Antonio, TX) in 0.1 M PBS0.5% Triton X-10010%
normal goat serum (NGS) for 12 to 16 hours at 4°C. Sections were then
washed in PBS (three times, 10 minutes each) and incubated in a goat
anti-rabbit IgG antibody conjugated to carboxymethylindocyanine
(Cy3; Jackson ImmunoResearch, West Grove, PA) at 1:100 to 1:200 for
1 hour. Some sections were counterstained with the nuclear stain 4,
6-diamidino-2-phenylindole hydrochloride (DAPI).
Alternatively, slides were pretreated in H2O2 (150 L/100 mL) and
thoroughly washed in PBS before incubation in CRY2 antibody. Slides
were then washed in PBS and transferred to goat anti-rabbit biotinyl-
ated secondary antibody (1:50; Jackson ImmunoResearch) for 2 hours.
After incubation and washing in PBS, sections were incubated in an
avidin-biotin-peroxidase mixture (Vectastain ABC kit; Vector Laborato-
ries, Burlingame, CA) for 1 hour and in 3,3-diaminobenzidine tetrahy-
drochloride (DAB; Sigma-Aldrich, St. Louis, MO) for 10 minutes fol-
lowed by brief treatment with DAB and 0.03% H2O2. Slides were
washed in PBS, coverslipped with a glycerin-PBS mixture, and analyzed
with a microscope equipped either with epifluorescence (Optiphot;
Nikon, Tokyo, Japan) or with differential interference contrast optics.
Antibody specificity was demonstrated either by eliminating primary
antibody or by preadsorption of antibody with 0.1 mg/mL CRY2
peptide (ADI) overnight at 4°C before incubation.
Antibody for Immunoblot Analysis
A rabbit polyclonal peptide CRY2 antibody was generated against a
synthetic peptide with the sequence CGGSSGPASPKRKLEAAEE (italic
region corresponds to residues 554-568 of human CRY2, or 553-567 of
mouse Cry2) conjugated to keyhole limpet hemocyanin (KLH). Rabbit
immunizations were performed in the presence of Freund’s adjuvant
by Covance Research Products, Inc. (Denver, PA), using their standard
118-day protocol. This antibody was purified from antiserum collected
TABLE 2. Primers Used for Real-Time Quantitative RT-PCR
Gene Acc. No.* 5 Primer 3 Primer Base Pairs† Amplicon (bp)‡
CRY1 D83702 CTCCATGGGCACTGGTCTCAGTG TCCCCACCAATTTCAGCTGCAAC 2251–2391† 141 (bp)‡
CRY2 AB014558 CCAAGAGGGAAGGGCAGGGTAGAG AGGATTTGAGGCACTGTTCCGAGG 3840–3964 125 (bp)‡
ACTB XM_037237 CCTCGCCTTTGCCGATCCG GCCGGAGCCGTTTGTCGACG 13–106 94 (bp)‡
* GenBank accession numbers; provided by the National Institutes of Health.
† Amplified region is indicated, using numbers from the GenBank file.
‡ Size of the amplified product
TABLE 1. Information on Human Donors Used for the Studies
Experiment Age, Sex
Time of
Death Cause of Death
Real-time RT-PCR 60 YO F 21:15 Breast cancer
Real-time RT-PCR 43 YO M 18:40 Anoxic brain injury
Real-time RT-PCR 74 YO F 14:10 Acute renal failure
Real-time RT-PCR 73 YO M 17:04 Lung cancer
Real-time RT-PCR 68 YO F 13:50 Leukemia
Real-time RT-PCR 56 YO F 01:55 Breast cancer
Real-time RT-PCR 32 YO F 11:35 End-stage renal disease
Immnohistochemistry 47 YO F 19:09 Cervical cancer
Biochemistry 59 YO M 07:40 Myocardial infarction
Biochemistry 58 YO M 11:45 Cervical cancer
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after three booster shots and was affinity purified with a recombinant
Cry2 protein crosslinked to agarose resin (AminoLink; Pierce, Rock-
ford, IL) according to the manufacturer’s instructions. The recombi-
nant protein used for purification was a fragment of the mouse Cry2 C
terminus (residues 373-592) fused to the C terminus of glutathione-S-
transferase (GST), which was purified on glutathione Sepharose (Phar-
macia, Piscataway, NJ) according to the manufacturer’s instructions.
Final antibody concentration was approximately 0.2 mg/mL.
Cell Lysates
Cell lysates were prepared from a stably transfected 293T cell line that
overexpresses recombinant human CRY2, using the construct
pSÖ2002 (which expresses hCRY2 with Myc, His, and Flag tags at the
carboxyl terminus24); transfected by calcium-phosphate precipita-
tion25; and selected with Zeocin (Invitrogen). Briefly, stably trans-
fected or untransfected 293T cells were grown in DMEM (Invitrogen-
Gibco) supplemented with 10% fetal bovine serum and after washing
with PBS, cells were collected and homogenized in ice-cold 1 mL lysis
buffer (50 mM Tris [pH 8.0], 150 mM NaCl, 0.02% sodium azide, 1%
NP40, 1 g/mL leupeptin, 1 g/mL pepstatin A, 10 mM iodoacetamide,
1 mM phenylmethylsulfonyl fluoride [PMSF]) yielding cell lysates at
final protein concentrations of 2.5 and 3.6 mg/mL, respectively.
Eyes were obtained from wild-type mice with a mixed background
of 129/Sv x C57BL/6 x C3H/HeJ, and rd/rd (retinal degeneration allele)
cry1/cry2/ (lacking both cryptochromes) triple-mutant mice
with the same background,16 in accordance with the ARVO Statement
for the Use of Animals in Ophthalmic and Vision Research. Retinal
lysates were prepared by homogenization of four eyes of each geno-
type in 1 mL lysis buffer.
Cell Fractionation
Human retina obtained from a fresh donor eye, in accordance with the
Declaration of Helsinki, was homogenized in 1 mL hypotonic lysis
buffer (5 mM N-ethylmaleimide, 10 mM EDTA, protease inhibitor
cocktail tablet; Complete Mini, EDTA-free; Roche Diagnostics, India-
napolis, IN) on ice in a prechilled 2-mL homogenizer (Dounce, Bellco
Glass Co, Vineland, NJ). The recovered retinal homogenate was placed
in a 1.5-mL microfuge tube, and nuclei were pelleted by centrifugation
for 30 seconds at 800g. The entire homogenate, less approximately 25
L (nuclear fraction), was layered over 250 L 2 M sucrose in a 2.0-mL
microfuge tube and centrifuged for 1 hour at 16,000g and 4°C. The top
layer, or cytosolic fraction, was carefully aspirated with a pipette and
transferred to a 1.5-mL tube, leaving behind the membranes at the
sucrose interface. The cytosol was centrifuged for 15 minutes at
30,000g to clear any remaining insoluble material or residual mem-
branes.
Immunoblot Analysis
Cell lysates were denatured in SDS reducing buffer, separated on a 10%
polyacrylamide gel, and transferred to a polyvinylidene difluoride
(PVDF) membrane (Bio-Rad). After the membrane was blocked for 1
hour in 10% fat-free milk and washed in TBST (three times, 10 minutes
each) it was incubated with the CRY2 peptide antibody at 1:3000
dilution (0.067 g/mL) overnight at 4°C. The blot was washed again in
TBST (three times, 10 minutes each), followed by incubation with a
1:5000 dilution of peroxidase-conjugated donkey anti-rabbit IgG (Jack-
son ImmunoResearch) for 1 hour at room temperature. After three
more washes in TBST, chemiluminescence reagent (ECL plus; Amer-
sham Biosciences, Arlington Heights, IL) was added for 5 minutes and
the Western blot was exposed to film (Biomax MRFilm; Eastman
Kodak, Rochester, NY).
Peptide Adsorption
The PVDF membrane used previously for CRY2 detection in cell lysates
was stripped for 30 minutes with 50 mM Tris (pH 6.5), 2% SDS, and 50
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a primary CRY2 antibody solution (0.067 g/mL, final concentration)
that had been preadsorbed by overnight incubation in a 15-mL solution
of CRY2-specific peptide (CGGSSGPASPKRKLEAAEE) at a final peptide
concentration of 13.3 g/mL.
RESULTS
Relative Gene Expression of CRY1 and CRY2
in Retina
Previous studies in the mouse have shown that mRNA expres-
sion of both cry1 and cry2 is restricted to the GCL and inner
nuclear layer (INL) of the retina and that there is qualitatively
more cry2 mRNA than cry1.17 To determine whether there is
a comparable expression profile of the cryptochrome genes in
the human retina, we quantitated CRY1 and CRY2 expression
by real-time RT-PCR in 4-mm punches of human tissue taken
from either the macula or midperipheral retina (Table 3, Fig.
1A). Strikingly, levels of CRY2 mRNAs were approximately 11
times higher than that of CRY1 in both macula and peripheral
retina (Table 3, Figs. 1A, 1C). In contrast to the expression
levels of CRY2 versus CRY1 transcripts observed in retina, in
the nonphotoreceptive tissue (placenta), levels of CRY2 mRNA
were slightly lower than CRY1, and only three times higher
than that of CRY1 in peripheral retina (Table 3, Figs. 1B, 1C).
Immunohistochemical Analysis of
CRY2 Expression
To establish CRY2 as a nonvisual photoreceptive molecule in
humans requires that its cellular distribution matches the
known localization of the circadian photoreceptor to the inner
retina. We therefore analyzed the expression of CRY2 by im-
munohistochemistry on transverse sections of normal adult
human retina.
In both the macula and peripheral retina, CRY2 immunore-
activity was present in numerous cells throughout the GCL
(Fig. 2). Some lightly immunostained cells were also present in
the proximal layers of the INL. In addition, occasional labeled
processes were observed in the inner plexiform (IPL) and
nerve fiber (NFL) layers. In the peripheral retina, robust CRY2
immunoreactivity appeared to be cytoplasmic, but a lower
level of nuclear labeling could not be ruled out, especially in
heavily stained cells. However, in the macula, there was clear
evidence for nuclear labeling. In fluorescence studies, sections
double labeled with anti-CRY2 and the nuclear stain DAPI
revealed that CRY2 immunoreactivity was present in most cells
in the GCL and that CRY2 localization is primarily cytoplasmic.
Finally, omission of the primary antibody, or peptide adsorp-
tion with the epitope-containing CRY2 peptide, eliminated all
staining, whereas adsorption with a nonspecific peptide did
not (data not shown), substantiating the specificity of CRY2
immunostaining.
Cytoplasmic Localization of CRY2
The nuclear, light-independent function of cryptochrome in
the transcriptional feedback loop underlying circadian rhythm
generation is known, and expression of cryptochromes in
mouse brain tissue and in cultured cells has been shown to be
primarily nuclear. However, the apparent localization of CRY2
immunoreactivity to the cytoplasm of retinal ganglion cells
could be indicative of a cell-specific, compartment-specific
function for CRY2. To confirm this localization, we fraction-
ated human retinal lysate into cytoplasmic and nuclear frac-
FIGURE 1. Quantitation of the relative levels of CRY1 and CRY2 mRNA in the human retina and placenta. Logarithmic fluorescence history versus
cycle number of target genes CRY1, CRY2, and reference gene ACTB in (A) macula and peripheral retina and (B) peripheral retina and placenta.
Trace colors for each sample (duplicate reactions) are shown below the graphs. (C) Summary of gene expression relative to CRY1 expression in
peripheral retina.
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tions and determined the subcellular localization of CRY2 pro-
tein by Western blot analysis.
For immunoblot analysis, we used an antibody separate
from that used for immunostaining. This antibody, which rec-
ognizes the recombinant CRY2 control (Fig. 3A, lane 2), rec-
ognized a band in the cytoplasmic fraction of human retinal
lysate (Fig. 3B, lane 1) that comigrated with the mouse Cry2
(mCry2) band (Fig. 3B, lane 2), consistent with the fact that the
human CRY2 sequence is only 1 amino acid longer than the
mCry2 sequence. The presumptive CRY2 band was eliminated
by peptide adsorption of the antibody (Fig. 3B, right panel).
Comparison of nuclear and cytoplasmic extracts demonstrated
the existence of CRY2 in both subcellular compartments (Fig.
3C).
DISCUSSION
Mammalian circadian photoreception has been localized to the
inner retina, but the responsible photopigment is unknown.
Because cryptochrome is an excellent candidate as a photopig-
ment regulating circadian photoentrainment and other nonvi-
sual photoresponses such as the pupillary light response, we
analyzed the pattern of cryptochrome expression in the human
retina.
In previous studies we determined that cry2 mRNA, and to
a lesser extent cry1, were expressed in the INL and GCL of the
mouse retina, with some expression also observed in photore-
ceptor nuclei.17 These semiquantitative data were obtained by
in situ hybridization and did not reveal relative differences
between cry1 and cry2 expression. Recombinant mouse cryp-
tochromes tagged with green fluorescent protein (GFP) or
hemagglutinin and overexpressed in cell culture exhibit a nu-
clear localization14,26,27; however, these conditions may not
accurately reflect cryptochrome expression in situ. Immuno-
cytochemical data have been reported for mouse crypto-
chromes in the SCN, where they are primarily nuclear,27 but
similar studies have not been performed in the retina. Indeed,
the proposed pleomorphic roles for cryptochromes16,28—a
circadian clock function in the SCN and a photoreceptive
function in the eye—suggest that either cryptochrome intra-
cellular localization or downstream targets could be different
between these two tissues to allow distinct functions.
In this study, we examined the distribution of CRY1 mRNA
and CRY2 mRNA and protein and found that CRY2 is the
primary cryptochrome expressed in human retina. In addition,
we report for the first time that a substantial portion of CRY2
protein exists in the cytoplasm of the human retina, as shown
both by the immunostaining and by immunoblot of fraction-
ated retinal lysates. In our analysis of subcellular localization,
we used two different antibodies against CRY2 in two different
assays, and both confirmed cytoplasmic localization of CRY2.
The relative paucity of the CRY1 transcript in retina may
explain, in part, why we were unable to detect CRY1 protein
by immunohistochemical methods (data not shown). These
data correlate well with the hypothesis that cryptochromes
perform partially overlapping functions, in which CRY1 is an
essential component of the molecular clock and CRY2 func-
tions predominantly as a photoreceptor. This is also supported
FIGURE 2. CRY2 immunoreactivity in the human retina. (A–C) Peripheral retina. (A) CRY2 immunoreac-
tivity was present throughout the cytoplasm of cells primarily located in the GCL. Occasional, lightly
stained cells were also present in the INL. (B) Higher magnification of (A). (C) In addition to labeled
somata, some immunostained processes were observed in the proximal IPL and in the NFL (arrows).
(D–F) Macula. (D) In the macula CRY2 immunoreactivity was present in cells throughout the GCL. (E)
Many cells in the GCL displayed strong CRY2 immunoreactivity throughout the cytoplasm. However, in
some cells labeling was restricted to the nucleus (arrow). (F) CRY2 immunostaining was eliminated in
sections incubated with CRY2 antibody preadsorbed with an epitope-containing peptide. (G–J) Double-
label histochemistry showing the distribution of CRY2 immunoreactivity compared with the overall
cellular density, as revealed by staining with the nuclear marker, DAPI (G, H: macula; I, J: peripheral
retina). Scale bars: (A, D–J) 50 m; (B, C) 25 m.
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by studies demonstrating that mice with only a single cry1
allele [out of four cry gene alleles (two cry 1; two cry 2)] have
sufficient clock function to maintain circadian rhythmicity in
constant darkness, but mice with a single cry2 allele do not.29
Because the cryptochromes are integral components of the
circadian clock, which regulates daily oscillation in mRNA and
protein abundance of both circadian clock genes and output
genes, the time of day at which human donor eyes were
harvested could affect quantitation of cryptochrome tran-
scripts. However, in the mouse, neither cry1 nor cry2 mRNA17
nor protein expression (Selby CP, Sancar A, unpublished ob-
servations, 1999) oscillates to a significant extent in retina.
Therefore, the quantitative PCR analysis of mRNA levels in the
human retina is unlikely to be affected by time of death of the
human donors.
The retinas of mammals, Xenopus, and chicken are known
to possess endogenous circadian pacemakers, and in Xenopus
this clock has been roughly localized to photoreceptor nuclei
in the outer retina.30 Presumably, if CRY1 is primarily respon-
sible for circadian clock function, it should be expressed in
photoreceptor nuclei. Supporting evidence comes from stud-
ies in the chicken, in which Cry1 mRNA is highly expressed in
photoreceptor nuclei and in the GCL.31 However, the finding
that human CRY2 is highly expressed at the mRNA level in the
retina, and particularly at the protein level in the cytoplasm of
ganglion cells, argues for a function for CRY2 not associated
with circadian rhythm maintenance in these cells. Further-
more, the detection of CRY2 in the cytoplasm of retinal gan-
glion cells suggests that phototransduction occurs outside the
nucleus, if this is the nonvisual photoreceptive molecule in
humans. Collectively, these studies, coupled with recent data
suggesting that the other candidate photopigment melanopsin
is in fact not required for robust circadian photoreception and
phototransduction,9 make the photoreceptive function of
cryptochromes, in particular CRY2, in the human retina more
compelling.
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